EDGAR Filing Documents for 0001415889-24-014450

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001415889-24-014450

Filing Date

2024-05-24

Accepted

2024-05-24 16:08:43

Documents

Period of Report

2024-05-22

Document Format Files

Seq	Description	Document	Type	Size
1		form4-05242024_080530.html	4
1		form4-05242024_080530.xml	4	4287
	Complete submission text file	0001415889-24-014450.txt		6082

Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142

Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075

KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KALVISTA PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE MA 02142

Business Address

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 24984349